INFEÇÕES VASCULARES PROTÉSICAS — UMA REVISÃO NARRATIVA
DOI:
https://doi.org/10.48750/acv.261Palavras-chave:
Infeção vascular prótesica, prótese vascular, revisãoResumo
As infeções vasculares protésicas continuam a ser um desafio médico complexo. A evolução da flora hospitalar e o desenvol- vimento da cirurgia vascular têm contribuído para uma mudança na realidade das infeções protésicas, tornando imperativo conhecer o contexto microbiológico atual destas infeções para o seu adequado tratamento. Estas infeções dependem de fatores endógenos e exógenos e variam consoante o tempo de apresentação, localização da prótese vascular e ambiente microbiológico do doente. A morbimortalidade associada a este diagnóstico é elevada e o tratamento deve ser adaptado ao doente em questão, sendo necessário conhecer o microrganismo e as várias possibilidades de tratamento existentes. O conhecimento dos fatores predisponentes da infeção protésica vascular, o seu reconhecimento precoce e prevenção deve ser realizada em todos os doentes e num contexto de cuidados de saúde multidisciplinares.
Downloads
Não há dados estatísticos.
Referências
1. Wilson WR, Bower TC, Creager MA, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation 2016;134:412–60.
2. SiracuseJJ,NandivadaP,GilesKA,etal.Prostheticgraftinfections involving the femoral artery. J Vasc Surg 2013;57:700–5.
3. Batt M, Feugier P, Camou F, et al. A meta-analysis of outcomes after in situ re- constructions for aortic graft infection. Angiology 2018;69(5):370–9.
4. O'Hara PJ, et al. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg. 1986;3:725.
5. Gharamti A, Kanafani ZA. Vascular Graft Infections- An update. Infect Dis Clin N Am. 2018 Dec;32(4):789-809
6. Rosenman JE, Pearce WH, Kempczinski RF. Bacterial adherence to vascular grafts after in vitro bacteremia. J Surg Res 1985;38:648–55.
7. Fatima J, Duncan AA, de Grandis E, et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg 2013;58:371–9.
8. Szilagyi DE, Smith RF, Elliott JP, et al. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972;176:321.
9. Bunt TJ. Synthetic vascular graft infections. I. Graft infections. Surgery 1983; 93(6):733-46.
10. Bunt, T.J., Synthetic vascular graft infections II: graft enteric erosion and graft enteric fistulae. Surgery 1983; 94:1–9.
11. Samson RH, Veith FJ, Janko GS, et al. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988;8:147–53.
12. Sidawy AN, Perler BA. Rutherford's Vascular Surgery And Endovascular Therapy (9th Edition). Elsevier. 2019: Ch 47: pp 588-682.
13. Hicks RC, Greenhalgh RM. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg 1997;14(Suppl A):5–9.
14. Durham JR, et al. The impact of multiple operations on the importance of arterial wall cultures. J Vasc Surg 1987;5:160.
15. Inui T, Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Seminars in vascular surgery 2015. 201–7.
16. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008;47:264–9.
17. Moore WS, Rosson CT, Hall AD, et al. Transient bacteremia: a cause of infection in prosthetic vascular grafts. Am J Surg 1969;117:342–3.
18. Thomas S, Ghosh J, Porter J, et al. Periodontal disease and late- -onset aortic prosthetic vascular graft infection. Case Rep Vasc Med 2015;2015:768935.
19. Vriesendorp T, Morelis Q, Devries J, et al. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endo- vasc Surg 2004;28:520–5.
20. Bowden MG, Chen W, Singvall J, et al. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology 2005;151:1453–64.
21. Davila VJ, Stone W, Duncan AA, et al. A multicenter experience with the surgical treatment of infected abdominal aortic endografts. J Vasc Surg 2015;62:877–83.
22. Sah BR, Husmann L, Mayer D, et al. Diagnostic performance of 18F-FDG-PET/ CT in vascular graft infections. Eur J Vasc Endovasc Surg 2015;49:455–64.
23. Kilic A, Arnaoutakis DJ, Reifsnyder T, et al. Management of infected vascular grafts. Vasc Med 2016;21:53–60.
24. Calligaro KD, et al. Selective preservation of infected prosthetic grafts: analysis of a 20-year experience with 120 extra-cavitary infected grafts. Ann Surg 1994;220:461.
25. Mayer D, et al. Long-term results of vascular graft and artery preser- ving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Ann Surg 2011;254:754.
26. Ricotta JJ, Faggioli GL, Stella A, et al. Total excision and extra-ana- tomic bypass for aortic graft infection. Am J Surg 1991;162:145–9.
27. Seeger JM, et al. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass and aortic graft removal. J Vasc Surg 2000;32:451
28. Clagett GP, et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg 1993;218:239.
29. Beck AW, et al. Aortic reconstruction with femoro-popliteal vein: graft stenosis incidence, risk and reintervention. J Vasc Surg 2008;47:36.
30. Oderich GS, Bower TC, Hofer J, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg 2011; 53(1):99-106, 107.e1-7.
31. Perler BA, et al. Rotational muscle flaps to treat localized prosthetic graft infection: long-term follow-up. J Vasc Surg 1993;18:358.
32. Silvestre L, Pedro LM, Fernandes RF, Silva E, Fernandes JF. Rectus femoris muscle flap based on proximal insertion mobilization to cover a groin infected vascular graft. J Vasc Surg 2015;62(4):1064-7.
33. Ban K, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines 2016 update. J Am Coll Surg 2017;224:59.
2. SiracuseJJ,NandivadaP,GilesKA,etal.Prostheticgraftinfections involving the femoral artery. J Vasc Surg 2013;57:700–5.
3. Batt M, Feugier P, Camou F, et al. A meta-analysis of outcomes after in situ re- constructions for aortic graft infection. Angiology 2018;69(5):370–9.
4. O'Hara PJ, et al. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg. 1986;3:725.
5. Gharamti A, Kanafani ZA. Vascular Graft Infections- An update. Infect Dis Clin N Am. 2018 Dec;32(4):789-809
6. Rosenman JE, Pearce WH, Kempczinski RF. Bacterial adherence to vascular grafts after in vitro bacteremia. J Surg Res 1985;38:648–55.
7. Fatima J, Duncan AA, de Grandis E, et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg 2013;58:371–9.
8. Szilagyi DE, Smith RF, Elliott JP, et al. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972;176:321.
9. Bunt TJ. Synthetic vascular graft infections. I. Graft infections. Surgery 1983; 93(6):733-46.
10. Bunt, T.J., Synthetic vascular graft infections II: graft enteric erosion and graft enteric fistulae. Surgery 1983; 94:1–9.
11. Samson RH, Veith FJ, Janko GS, et al. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg 1988;8:147–53.
12. Sidawy AN, Perler BA. Rutherford's Vascular Surgery And Endovascular Therapy (9th Edition). Elsevier. 2019: Ch 47: pp 588-682.
13. Hicks RC, Greenhalgh RM. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg 1997;14(Suppl A):5–9.
14. Durham JR, et al. The impact of multiple operations on the importance of arterial wall cultures. J Vasc Surg 1987;5:160.
15. Inui T, Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Seminars in vascular surgery 2015. 201–7.
16. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008;47:264–9.
17. Moore WS, Rosson CT, Hall AD, et al. Transient bacteremia: a cause of infection in prosthetic vascular grafts. Am J Surg 1969;117:342–3.
18. Thomas S, Ghosh J, Porter J, et al. Periodontal disease and late- -onset aortic prosthetic vascular graft infection. Case Rep Vasc Med 2015;2015:768935.
19. Vriesendorp T, Morelis Q, Devries J, et al. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endo- vasc Surg 2004;28:520–5.
20. Bowden MG, Chen W, Singvall J, et al. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology 2005;151:1453–64.
21. Davila VJ, Stone W, Duncan AA, et al. A multicenter experience with the surgical treatment of infected abdominal aortic endografts. J Vasc Surg 2015;62:877–83.
22. Sah BR, Husmann L, Mayer D, et al. Diagnostic performance of 18F-FDG-PET/ CT in vascular graft infections. Eur J Vasc Endovasc Surg 2015;49:455–64.
23. Kilic A, Arnaoutakis DJ, Reifsnyder T, et al. Management of infected vascular grafts. Vasc Med 2016;21:53–60.
24. Calligaro KD, et al. Selective preservation of infected prosthetic grafts: analysis of a 20-year experience with 120 extra-cavitary infected grafts. Ann Surg 1994;220:461.
25. Mayer D, et al. Long-term results of vascular graft and artery preser- ving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Ann Surg 2011;254:754.
26. Ricotta JJ, Faggioli GL, Stella A, et al. Total excision and extra-ana- tomic bypass for aortic graft infection. Am J Surg 1991;162:145–9.
27. Seeger JM, et al. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass and aortic graft removal. J Vasc Surg 2000;32:451
28. Clagett GP, et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg 1993;218:239.
29. Beck AW, et al. Aortic reconstruction with femoro-popliteal vein: graft stenosis incidence, risk and reintervention. J Vasc Surg 2008;47:36.
30. Oderich GS, Bower TC, Hofer J, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg 2011; 53(1):99-106, 107.e1-7.
31. Perler BA, et al. Rotational muscle flaps to treat localized prosthetic graft infection: long-term follow-up. J Vasc Surg 1993;18:358.
32. Silvestre L, Pedro LM, Fernandes RF, Silva E, Fernandes JF. Rectus femoris muscle flap based on proximal insertion mobilization to cover a groin infected vascular graft. J Vasc Surg 2015;62(4):1064-7.
33. Ban K, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines 2016 update. J Am Coll Surg 2017;224:59.
Downloads
Publicado
2020-02-07
Como Citar
1.
Gouveia e Melo R, Santos CM, Fernandes e Fernandes R, Garrido P, Pedro LM. INFEÇÕES VASCULARES PROTÉSICAS — UMA REVISÃO NARRATIVA. Angiol Cir Vasc [Internet]. 7 de Fevereiro de 2020 [citado 23 de Novembro de 2024];15(4):250-5. Disponível em: https://acvjournal.com/index.php/acv/article/view/261
Edição
Secção
Artigo de Revisão
